25 XP   0   0   10

Equillium Inc
Buy, Hold or Sell?

Let's analyse Equillium Inc together

PenkeI guess you are interested in Equillium Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Equillium Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Equillium Inc

I send you an email if I find something interesting about Equillium Inc.

Quick analysis of Equillium Inc (30 sec.)










What can you expect buying and holding a share of Equillium Inc? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€0.61
Expected worth in 1 year
€0.35
How sure are you?
22.2%

+ What do you gain per year?

Total Gains per Share
€-0.25
Return On Investment
-15.5%

For what price can you sell your share?

Current Price per Share
€1.62
Expected price per share
€0.784 - €2.545
How sure are you?
50%

1. Valuation of Equillium Inc (5 min.)




Live pricePrice per Share (EOD)

€1.62

Intrinsic Value Per Share

€-1.01 - €-0.97

Total Value Per Share

€-0.40 - €-0.36

2. Growth of Equillium Inc (5 min.)




Is Equillium Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$22.5m$38.2m-$12.5m-48.6%

How much money is Equillium Inc making?

Current yearPrevious yearGrowGrow %
Making money-$3.3m-$15.6m$12.2m368.2%
Net Profit Margin-37.1%4.4%--

How much money comes from the company's main activities?

3. Financial Health of Equillium Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#579 / 1019

Most Revenue
#311 / 1019

Most Profit
#364 / 1019

Most Efficient
#525 / 1019

What can you expect buying and holding a share of Equillium Inc? (5 min.)

Welcome investor! Equillium Inc's management wants to use your money to grow the business. In return you get a share of Equillium Inc.

What can you expect buying and holding a share of Equillium Inc?

First you should know what it really means to hold a share of Equillium Inc. And how you can make/lose money.

Speculation

The Price per Share of Equillium Inc is €1.624. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Equillium Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Equillium Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.61. Based on the TTM, the Book Value Change Per Share is €-0.06 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.23 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Equillium Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.07-4.1%-0.09-5.6%-0.44-27.4%-0.25-15.4%-0.25-15.4%
Usd Book Value Change Per Share-0.04-2.7%-0.07-4.1%-0.25-15.1%0.042.2%0.042.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.04-2.7%-0.07-4.1%-0.25-15.1%0.042.2%0.042.2%
Usd Price Per Share0.62-0.69-2.07-2.92-2.92-
Price to Earnings Ratio-2.31--1.93--0.19--2.96--2.96-
Price-to-Total Gains Ratio-14.12--10.74--3.07--9.29--9.29-
Price to Book Ratio0.96-0.94-1.93-1.98-1.98-
Price-to-Total Gains Ratio-14.12--10.74--3.07--9.29--9.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.7248504
Number of shares579
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.070.04
Usd Total Gains Per Share-0.070.04
Gains per Quarter (579 shares)-38.6120.67
Gains per Year (579 shares)-154.4682.70
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-154-16408373
20-309-3180165156
30-463-4720248239
40-618-6260331322
50-772-7800413405
60-927-9340496488
70-1081-10880579571
80-1236-12420662654
90-1390-13960744737
100-1545-15500827820

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.017.00.05.6%1.017.00.05.6%1.017.00.05.6%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%4.014.00.022.2%4.014.00.022.2%4.014.00.022.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.018.00.0%0.00.018.00.0%0.00.018.00.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%4.014.00.022.2%4.014.00.022.2%4.014.00.022.2%

Fundamentals of Equillium Inc

About Equillium Inc

Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a first-in-class monoclonal antibody that targets the immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase I clinical trial for the treatment of ulcerative colitis; and Phase I clinical trial for the treatment of lupus nephritis. It also develops EQ101 completed phase 1/2 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ302 to treat gastrointestinal indications. In addition, it serves dermatology, gastroenterology, rheumatology, hematology, transplant science, oncology, and pulmonology area. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.

Fundamental data was last updated by Penke on 2024-04-05 06:22:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Equillium Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Equillium Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Equillium Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -25.4% means that €-0.25 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Equillium Inc:

  • The MRQ is -25.4%. The company is making a huge loss. -2
  • The TTM is -37.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-25.4%TTM-37.1%+11.6%
TTM-37.1%YOY4.4%-41.5%
TTM-37.1%5Y-7.3%-29.8%
5Y-7.3%10Y-7.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-25.4%-197.2%+171.8%
TTM-37.1%-210.4%+173.3%
YOY4.4%-279.3%+283.7%
5Y-7.3%-436.8%+429.5%
10Y-7.3%-599.3%+592.0%
1.1.2. Return on Assets

Shows how efficient Equillium Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Equillium Inc to the Biotechnology industry mean.
  • -4.6% Return on Assets means that Equillium Inc generated €-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Equillium Inc:

  • The MRQ is -4.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.6%TTM-5.6%+1.0%
TTM-5.6%YOY-24.4%+18.8%
TTM-5.6%5Y-12.9%+7.3%
5Y-12.9%10Y-12.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.6%-13.6%+9.0%
TTM-5.6%-12.9%+7.3%
YOY-24.4%-11.9%-12.5%
5Y-12.9%-14.2%+1.3%
10Y-12.9%-16.2%+3.3%
1.1.3. Return on Equity

Shows how efficient Equillium Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Equillium Inc to the Biotechnology industry mean.
  • -10.4% Return on Equity means Equillium Inc generated €-0.10 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Equillium Inc:

  • The MRQ is -10.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -12.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.4%TTM-12.9%+2.5%
TTM-12.9%YOY-36.5%+23.6%
TTM-12.9%5Y-19.0%+6.1%
5Y-19.0%10Y-19.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.4%-17.0%+6.6%
TTM-12.9%-16.1%+3.2%
YOY-36.5%-15.4%-21.1%
5Y-19.0%-20.0%+1.0%
10Y-19.0%-21.1%+2.1%

1.2. Operating Efficiency of Equillium Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Equillium Inc is operating .

  • Measures how much profit Equillium Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Equillium Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Equillium Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-20.1%+20.1%
TTM-20.1%YOY3.2%-23.3%
TTM-20.1%5Y-3.7%-16.3%
5Y-3.7%10Y-3.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--286.1%+286.1%
TTM-20.1%-224.4%+204.3%
YOY3.2%-288.4%+291.6%
5Y-3.7%-475.2%+471.5%
10Y-3.7%-624.7%+621.0%
1.2.2. Operating Ratio

Measures how efficient Equillium Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.35 means that the operating costs are €1.35 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Equillium Inc:

  • The MRQ is 1.347. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.403. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.347TTM1.403-0.056
TTM1.403YOY0.218+1.185
TTM1.4035Y0.360+1.043
5Y0.36010Y0.3600.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3472.997-1.650
TTM1.4033.247-1.844
YOY0.2183.766-3.548
5Y0.3605.675-5.315
10Y0.3607.857-7.497

1.3. Liquidity of Equillium Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Equillium Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.79 means the company has €1.79 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Equillium Inc:

  • The MRQ is 1.790. The company is able to pay all its short-term debts. +1
  • The TTM is 2.042. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.790TTM2.042-0.252
TTM2.042YOY3.752-1.710
TTM2.0425Y9.104-7.062
5Y9.10410Y9.1040.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7903.930-2.140
TTM2.0424.251-2.209
YOY3.7525.436-1.684
5Y9.1046.045+3.059
10Y9.1046.363+2.741
1.3.2. Quick Ratio

Measures if Equillium Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Equillium Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.78 means the company can pay off €0.78 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Equillium Inc:

  • The MRQ is 0.776. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.952. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.776TTM0.952-0.176
TTM0.952YOY1.797-0.845
TTM0.9525Y4.186-3.234
5Y4.18610Y4.1860.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7763.629-2.853
TTM0.9524.065-3.113
YOY1.7975.397-3.600
5Y4.1865.993-1.807
10Y4.1866.277-2.091

1.4. Solvency of Equillium Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Equillium Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Equillium Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.55 means that Equillium Inc assets are financed with 55.3% credit (debt) and the remaining percentage (100% - 55.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Equillium Inc:

  • The MRQ is 0.553. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.562. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.553TTM0.562-0.009
TTM0.562YOY0.415+0.147
TTM0.5625Y0.332+0.230
5Y0.33210Y0.3320.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5530.332+0.221
TTM0.5620.334+0.228
YOY0.4150.268+0.147
5Y0.3320.366-0.034
10Y0.3320.390-0.058
1.4.2. Debt to Equity Ratio

Measures if Equillium Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Equillium Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 123.9% means that company has €1.24 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Equillium Inc:

  • The MRQ is 1.239. The company is able to pay all its debts with equity. +1
  • The TTM is 1.290. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.239TTM1.290-0.051
TTM1.290YOY0.786+0.504
TTM1.2905Y0.609+0.681
5Y0.60910Y0.6090.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2390.381+0.858
TTM1.2900.390+0.900
YOY0.7860.334+0.452
5Y0.6090.434+0.175
10Y0.6090.466+0.143

2. Market Valuation of Equillium Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Equillium Inc generates.

  • Above 15 is considered overpriced but always compare Equillium Inc to the Biotechnology industry mean.
  • A PE ratio of -2.31 means the investor is paying €-2.31 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Equillium Inc:

  • The EOD is -6.466. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.313. Based on the earnings, the company is expensive. -2
  • The TTM is -1.927. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.466MRQ-2.313-4.153
MRQ-2.313TTM-1.927-0.386
TTM-1.927YOY-0.187-1.740
TTM-1.9275Y-2.960+1.033
5Y-2.96010Y-2.9600.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.466-2.315-4.151
MRQ-2.313-2.560+0.247
TTM-1.927-2.664+0.737
YOY-0.187-4.122+3.935
5Y-2.960-6.258+3.298
10Y-2.960-6.108+3.148
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Equillium Inc:

  • The EOD is -2.657. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.951. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.499. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.657MRQ-0.951-1.707
MRQ-0.951TTM-1.499+0.548
TTM-1.499YOY-1.256-0.243
TTM-1.4995Y-3.040+1.542
5Y-3.04010Y-3.0400.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.657-3.067+0.410
MRQ-0.951-3.251+2.300
TTM-1.499-3.545+2.046
YOY-1.256-5.595+4.339
5Y-3.040-8.315+5.275
10Y-3.040-8.708+5.668
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Equillium Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.96 means the investor is paying €0.96 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Equillium Inc:

  • The EOD is 2.684. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.960. Based on the equity, the company is cheap. +2
  • The TTM is 0.942. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD2.684MRQ0.960+1.724
MRQ0.960TTM0.942+0.018
TTM0.942YOY1.935-0.993
TTM0.9425Y1.982-1.040
5Y1.98210Y1.9820.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.6841.905+0.779
MRQ0.9602.111-1.151
TTM0.9422.095-1.153
YOY1.9352.836-0.901
5Y1.9823.443-1.461
10Y1.9823.794-1.812
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Equillium Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.041-0.063+53%-0.232+463%0.034-222%0.034-222%
Book Value Per Share--0.6050.690-12%1.025-41%1.312-54%1.312-54%
Current Ratio--1.7902.042-12%3.752-52%9.104-80%9.104-80%
Debt To Asset Ratio--0.5530.562-2%0.415+33%0.332+67%0.332+67%
Debt To Equity Ratio--1.2391.290-4%0.786+58%0.609+103%0.609+103%
Dividend Per Share----0%-0%-0%-0%
Eps---0.063-0.085+36%-0.418+566%-0.235+274%-0.235+274%
Free Cash Flow Per Share---0.153-0.146-4%-0.060-60%-0.147-4%-0.147-4%
Free Cash Flow To Equity Per Share---0.151-0.250+66%-0.077-49%-0.035-77%-0.035-77%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.967--------
Intrinsic Value_10Y_min---1.008--------
Intrinsic Value_1Y_max---0.496--------
Intrinsic Value_1Y_min---0.488--------
Intrinsic Value_3Y_max---1.186--------
Intrinsic Value_3Y_min---1.139--------
Intrinsic Value_5Y_max---1.510--------
Intrinsic Value_5Y_min---1.428--------
Market Cap57033580.800+64%20404283.08822669450.572-10%68482440.000-70%96484150.349-79%96484150.349-79%
Net Profit Margin---0.254-0.371+46%0.044-678%-0.073-71%-0.073-71%
Operating Margin----0.2010%0.032-100%-0.0370%-0.0370%
Operating Ratio--1.3471.403-4%0.218+519%0.360+274%0.360+274%
Pb Ratio2.684+64%0.9600.942+2%1.935-50%1.982-52%1.982-52%
Pe Ratio-6.466-180%-2.313-1.927-17%-0.187-92%-2.960+28%-2.960+28%
Price Per Share1.624+64%0.5810.646-10%1.950-70%2.747-79%2.747-79%
Price To Free Cash Flow Ratio-2.657-180%-0.951-1.499+58%-1.256+32%-3.040+220%-3.040+220%
Price To Total Gains Ratio-39.463-180%-14.118-10.743-24%-3.074-78%-9.291-34%-9.291-34%
Quick Ratio--0.7760.952-19%1.797-57%4.186-81%4.186-81%
Return On Assets---0.046-0.056+22%-0.244+426%-0.129+178%-0.129+178%
Return On Equity---0.104-0.129+24%-0.365+252%-0.190+83%-0.190+83%
Total Gains Per Share---0.041-0.063+53%-0.232+463%0.034-222%0.034-222%
Usd Book Value--22572258.47725731904.679-12%38248493.496-41%48942558.851-54%48942558.851-54%
Usd Book Value Change Per Share---0.044-0.067+53%-0.246+463%0.036-222%0.036-222%
Usd Book Value Per Share--0.6430.733-12%1.089-41%1.394-54%1.394-54%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.067-0.091+36%-0.444+566%-0.249+274%-0.249+274%
Usd Free Cash Flow---5698812.788-5458070.696-4%-2252925.989-60%-4878117.526-14%-4878117.526-14%
Usd Free Cash Flow Per Share---0.162-0.155-4%-0.064-60%-0.156-4%-0.156-4%
Usd Free Cash Flow To Equity Per Share---0.160-0.265+66%-0.081-49%-0.037-77%-0.037-77%
Usd Market Cap60575366.168+64%21671389.06824077223.453-10%72735199.524-70%102475816.086-79%102475816.086-79%
Usd Price Per Share1.725+64%0.6170.686-10%2.071-70%2.918-79%2.918-79%
Usd Profit---2341923.065-3333640.486+42%-15606487.310+566%-8789100.157+275%-8789100.157+275%
Usd Revenue--9210697.4199020703.660+2%3939620.579+134%2880072.053+220%2880072.053+220%
Usd Total Gains Per Share---0.044-0.067+53%-0.246+463%0.036-222%0.036-222%
 EOD+5 -3MRQTTM+18 -14YOY+13 -205Y+8 -2410Y+8 -24

3.2. Fundamental Score

Let's check the fundamental score of Equillium Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.466
Price to Book Ratio (EOD)Between0-12.684
Net Profit Margin (MRQ)Greater than0-0.254
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.776
Current Ratio (MRQ)Greater than11.790
Debt to Asset Ratio (MRQ)Less than10.553
Debt to Equity Ratio (MRQ)Less than11.239
Return on Equity (MRQ)Greater than0.15-0.104
Return on Assets (MRQ)Greater than0.05-0.046
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Equillium Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.646
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets50,530
Total Liabilities27,957
Total Stockholder Equity22,573
 As reported
Total Liabilities 27,957
Total Stockholder Equity+ 22,573
Total Assets = 50,530

Assets

Total Assets50,530
Total Current Assets49,349
Long-term Assets1,181
Total Current Assets
Cash And Cash Equivalents 23,216
Short-term Investments 17,650
Net Receivables 3,735
Other Current Assets 235
Total Current Assets  (as reported)49,349
Total Current Assets  (calculated)44,836
+/- 4,513
Long-term Assets
Property Plant Equipment 1,111
Long-term Assets Other 70
Long-term Assets  (as reported)1,181
Long-term Assets  (calculated)1,181
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities27,573
Long-term Liabilities384
Total Stockholder Equity22,573
Total Current Liabilities
Accounts payable 4,707
Total Current Liabilities  (as reported)27,573
Total Current Liabilities  (calculated)4,707
+/- 22,866
Long-term Liabilities
Long-term Liabilities  (as reported)384
Long-term Liabilities  (calculated)0
+/- 384
Total Stockholder Equity
Total Stockholder Equity (as reported)22,573
Total Stockholder Equity (calculated)0
+/- 22,573
Other
Capital Stock3
Common Stock Shares Outstanding 35,119
Net Invested Capital 22,573
Net Working Capital 21,776
Property Plant and Equipment Gross 1,475



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
62,995
55,539
49,911
44,259
92,385
85,428
106,838
99,837
92,470
85,405
74,235
62,472
48,631
78,421
71,790
58,764
55,225
50,530
50,53055,22558,76471,79078,42148,63162,47274,23585,40592,47099,837106,83885,42892,38544,25949,91155,53962,995
   > Total Current Assets 
62,909
55,431
49,822
44,178
92,160
85,174
106,615
99,566
92,170
83,370
72,085
60,482
46,776
76,735
70,220
57,356
53,911
49,349
49,34953,91157,35670,22076,73546,77660,48272,08583,37092,17099,566106,61585,17492,16044,17849,82255,43162,909
       Cash And Cash Equivalents 
27,657
13,219
20,614
24,083
49,249
23,982
50,861
73,525
77,155
50,366
26,244
23,808
25,729
59,107
24,503
25,624
34,382
23,216
23,21634,38225,62424,50359,10725,72923,80826,24450,36677,15573,52550,86123,98249,24924,08320,61413,21927,657
       Short-term Investments 
34,581
39,924
27,061
18,523
41,288
58,181
53,218
24,118
13,539
30,345
42,579
33,754
18,793
11,916
37,489
22,754
11,924
17,650
17,65011,92422,75437,48911,91618,79333,75442,57930,34513,53924,11853,21858,18141,28818,52327,06139,92434,581
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
2,838
3,424
5,943
5,469
3,735
3,7355,4695,9433,4242,8380000000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
3,262
2,920
2,254
3,369
4,804
5,235
3,836
235
2353,8365,2354,8043,3692,2542,9203,2620000000000
   > Long-term Assets 
86
108
89
81
225
254
223
271
300
1,645
2,150
1,990
1,855
1,191
1,570
1,408
1,314
1,181
1,1811,3141,4081,5701,1911,8551,9902,1501,645300271223254225818910886
       Property Plant Equipment 
71
93
89
81
225
239
223
254
243
1,882
2,005
1,869
1,742
1,191
1,474
1,321
1,235
1,111
1,1111,2351,3211,4741,1911,7421,8692,0051,88224325422323922581899371
       Other Assets 
15
15
0
0
0
15
0
17
57
153
145
121
113
104
0
87
79
0
07987010411312114515357170150001515
> Total Liabilities 
14,036
13,691
13,565
13,287
14,259
15,574
14,958
15,064
16,668
18,900
21,605
22,205
20,471
46,479
42,521
31,783
31,117
27,957
27,95731,11731,78342,52146,47920,47122,20521,60518,90016,66815,06414,95815,57414,25913,28713,56513,69114,036
   > Total Current Liabilities 
4,274
3,883
3,711
3,387
5,145
7,245
7,417
4,980
7,778
8,915
13,113
15,188
14,930
32,038
32,020
25,218
28,199
27,573
27,57328,19925,21832,02032,03814,93015,18813,1138,9157,7784,9807,4177,2455,1453,3873,7113,8834,274
       Short Long Term Debt 
0
0
0
0
833
1,666
2,500
0
1,250
1,428
2,857
4,286
5,714
5,714
5,714
0
0
0
0005,7145,7145,7144,2862,8571,4281,25002,5001,6668330000
       Accounts payable 
2,675
1,873
1,801
1,761
1,681
2,766
2,324
1,816
2,669
1,225
4,210
5,091
2,469
3,977
5,692
3,026
3,635
4,707
4,7073,6353,0265,6923,9772,4695,0914,2101,2252,6691,8162,3242,7661,6811,7611,8011,8732,675
       Other Current Liabilities 
0
0
0
0
0
0
7,417
0
0
0
0
0
0
14,700
0
14,239
16,396
0
016,39614,239014,7000000007,417000000
   > Long-term Liabilities 
9,762
9,808
9,854
9,900
9,114
8,329
7,541
10,084
8,890
9,985
8,492
7,017
5,541
14,441
10,501
6,565
2,918
384
3842,9186,56510,50114,4415,5417,0178,4929,9858,89010,0847,5418,3299,1149,9009,8549,8089,762
       Long term Debt 
9,616
9,681
9,746
9,810
9,043
8,275
7,506
10,067
8,873
8,750
7,370
5,992
4,616
3,239
1,841
0
0
0
0001,8413,2394,6165,9927,3708,7508,87310,0677,5068,2759,0439,8109,7469,6819,616
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
1,235
1,542
1,459
1,346
1,232
1,123
1,025
926
824
8249261,0251,1231,2321,3461,4591,5421,235000000000
       Other Liabilities 
146
127
108
90
71
54
35
17
17
0
0
0
0
10,378
0
5,956
2,420
0
02,4205,956010,3780000171735547190108127146
       Long-term Liabilities Other 
146
127
108
90
71
54
35
17
17
0
0
0
0
4,063
0
0
0
0
00004,0630000171735547190108127146
> Total Stockholder Equity
48,959
41,848
36,346
30,972
78,126
69,854
91,880
84,773
75,802
66,505
52,630
40,267
28,160
31,942
29,269
26,981
24,108
22,573
22,57324,10826,98129,26931,94228,16040,26752,63066,50575,80284,77391,88069,85478,12630,97236,34641,84848,959
   Common Stock
1
1
1
1
2
2
2
2
2
2
3
3
3
3
0
3
3
0
033033332222221111
   Retained Earnings Total Equity000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
80
21
474
97
-30
-297
-255
-209
-66
-138
-454
-149
193
76
0
340
458
0
0458340076193-149-454-138-66-209-255-297-30974742180



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue36,084
Cost of Revenue--
Gross Profit-36,084
 
Operating Income (+$)
Gross Profit-
Operating Expense-50,606
Operating Income-14,522-50,606
 
Operating Expense (+$)
Research Development37,039
Selling General Administrative13,567
Selling And Marketing Expenses-
Operating Expense50,60650,606
 
Net Interest Income (+$)
Interest Income2,334
Interest Expense-491
Other Finance Cost-0
Net Interest Income1,843
 
Pretax Income (+$)
Operating Income-14,522
Net Interest Income1,843
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-12,755-14,446
EBIT - interestExpense = -491
-13,335
-12,844
Interest Expense491
Earnings Before Interest and Taxes (EBIT)--12,264
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-12,755
Tax Provision-580
Net Income From Continuing Ops-13,335-13,335
Net Income-13,335
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-76-1,843
 

Technical Analysis of Equillium Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Equillium Inc. The general trend of Equillium Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Equillium Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Equillium Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.784 < 2.155 < 2.545.

The bearish price targets are: 1.141 > 0.86 > 0.784.

Tweet this
Equillium Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Equillium Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Equillium Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Equillium Inc.

Equillium Inc Daily Moving Average Convergence/Divergence (MACD) ChartEquillium Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Equillium Inc. The current adx is .

Equillium Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Equillium Inc.

Equillium Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Equillium Inc.

Equillium Inc Daily Relative Strength Index (RSI) ChartEquillium Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Equillium Inc.

Equillium Inc Daily Stochastic Oscillator ChartEquillium Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Equillium Inc.

Equillium Inc Daily Commodity Channel Index (CCI) ChartEquillium Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Equillium Inc.

Equillium Inc Daily Chande Momentum Oscillator (CMO) ChartEquillium Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Equillium Inc.

Equillium Inc Daily Williams %R ChartEquillium Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Equillium Inc.

Equillium Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Equillium Inc.

Equillium Inc Daily Average True Range (ATR) ChartEquillium Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Equillium Inc.

Equillium Inc Daily On-Balance Volume (OBV) ChartEquillium Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Equillium Inc.

Equillium Inc Daily Money Flow Index (MFI) ChartEquillium Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Equillium Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-30 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-05 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-07 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-19 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-22 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-28 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-17 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-25 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-31 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-01 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-06 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-09 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-14 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-15 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-22 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-26 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-29 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-05 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-19 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-22 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-25 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-05 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-09 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-10 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Equillium Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Equillium Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.646
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Equillium Inc with someone you think should read this too:
  • Are you bullish or bearish on Equillium Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Equillium Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Equillium Inc

I send you an email if I find something interesting about Equillium Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Equillium Inc.

Receive notifications about Equillium Inc in your mailbox!